Viracta Therapeutics Management
Management criteria checks 2/4
Viracta Therapeutics' CEO is Mark Rothera, appointed in Sep 2022, has a tenure of 1.67 years. total yearly compensation is $5.72M, comprised of 2.9% salary and 97.1% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth $81.96K. The average tenure of the management team and the board of directors is 2.8 years and 3.3 years respectively.
Key information
Mark Rothera
Chief executive officer
US$5.7m
Total compensation
| CEO salary percentage | 2.9% |
| CEO tenure | 1.7yrs |
| CEO ownership | 0.3% |
| Management average tenure | 2.8yrs |
| Board average tenure | 3.3yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$51m |
| Sep 30 2023 | n/a | n/a | -US$48m |
| Jun 30 2023 | n/a | n/a | -US$53m |
| Mar 31 2023 | n/a | n/a | -US$51m |
| Dec 31 2022 | US$6m | US$167k | -US$49m |
Compensation vs Market: Mark's total compensation ($USD5.72M) is above average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: Insufficient data to compare Mark's compensation with company performance.
CEO
Mark Rothera (60 yo)
1.7yrs
Tenure
US$5,720,657
Compensation
Mr. Mark Andrew Rothera serves as Chief Executive Officer, President & Director of Viracta Therapeutics, Inc. since September 19, 2022. He served as President, Chief Executive Officer and Executive Directo...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.7yrs | US$5.72m | 0.25% $ 82.0k | |
| Scientific Founder and Consultant | 13.4yrs | no data | no data | |
| Co-Founder and Consultant | 13.4yrs | no data | no data | |
| Co-Founder | no data | no data | no data | |
| Co-Founder | no data | no data | no data | |
| Co-Founder | no data | no data | no data | |
| Scientific Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Senior VP of Finance | less than a year | no data | no data | |
| Chief Scientific Officer | 2.8yrs | no data | no data | |
| Senior VP of Legal Affairs & General Counsel | 2.3yrs | no data | no data | |
| Senior Vice President of Regulatory Affairs | 3.2yrs | no data | no data | |
| Senior Vice President of Business Development & Corporate Strategy | 2.8yrs | no data | no data |
2.8yrs
Average Tenure
64yo
Average Age
Experienced Management: VIRX's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.7yrs | US$5.72m | 0.25% $ 82.0k | |
| Scientific Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Director | 3.3yrs | US$3.54m | 1.99% $ 641.5k | |
| Independent Director | 3.3yrs | US$158.70k | 0% $ 0 | |
| Member of Scientific Advisory Board | 5.7yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.7yrs | no data | no data | |
| Independent Director | 3.2yrs | US$156.20k | 0% $ 0 | |
| Independent Chairman of the Board | 3.3yrs | US$322.79k | 0.25% $ 81.4k | |
| Member of Scientific Advisory Board | 5.7yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.7yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.7yrs | no data | no data | |
| Independent Director | 3.2yrs | US$153.70k | 0% $ 0 |
3.3yrs
Average Tenure
66yo
Average Age
Experienced Board: VIRX's board of directors are considered experienced (3.3 years average tenure).